Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Inhibition of connexin 26 by the AMP-activated protein kinase.
Alesutan I, Sopjani M, Munoz C, Fraser S, Kemp BE, Föller M, Lang F.
???displayArticle.abstract???
Connexins provide intercellular connections that allow passage of ions and small organic molecules. They clamp the cell membrane potential and cellular ion composition to that of neighboring cells. The cell membrane potential and ion composition of an energy-depleted cell could thus be maintained despite its compromised Na(+)/K(+) activity. By the same token, however, the breakdown of ion gradients in that cell imposes an additional challenge to the neighboring cells, which may jeopardize their survival. Thus, timely closure of connexins may be critically important for the survival of those cells. Energy depletion stimulates the AMP-activated protein kinase (AMPK), a serine/threonine kinase that senses energy depletion and stimulates several cellular mechanisms to enhance energy production and to limit energy utilization. The present study explored whether AMPK regulates connexin 26. To this end, cRNA encoding connexin 26 was injected into Xenopus oocytes with and without additional injection of wild-type AMPK (α1β1γ1), of the constitutively active (γR70Q)AMPK (α1β1γ1[R70Q]) or of the inactive mutant (αK45R)AMPK (α1[K45R]β1γ1). Connexin 26 activity was determined in dual-electrode voltage-clamp experiments. Moreover, connexin 26 abundance was determined in the oocytecell membrane by chemiluminescence and confocal microscopy. As a result, connexin 26-mediated current and connexin 26 protein abundance were significantly decreased by coexpression of (γR70Q)AMPK and, to a lower extent, by wild-type AMPK but not by (αK45R)AMPK. In conclusion, AMPK is a potent regulator of connexin 26.
Ahmad,
Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice.
2003, Pubmed
Ahmad,
Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice.
2003,
Pubmed Almaça,
AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated.
2009,
Pubmed Alzamora,
AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells.
2010,
Pubmed
,
Xenbase Arndt,
A novel dominant and a de novo mutation in the GJB2 gene (connexin-26) cause keratitis-ichthyosis-deafness syndrome: implication for cochlear implantation.
2010,
Pubmed Becker,
Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.
2007,
Pubmed Bhalla,
AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2.
2006,
Pubmed
,
Xenbase Boehmer,
The peptide transporter PEPT2 is targeted by the protein kinase SGK1 and the scaffold protein NHERF2.
2008,
Pubmed
,
Xenbase Bolon,
Abrupt reoxygenation following hypoxia reduces electrical coupling between endothelial cells of wild-type but not connexin40 null mice in oxidant- and PKA-dependent manner.
2005,
Pubmed Bortner,
The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis.
2004,
Pubmed Brézillon,
ATP depletion induces a loss of respiratory epithelium functional integrity and down-regulates CFTR (cystic fibrosis transmembrane conductance regulator) expression.
1997,
Pubmed Carattino,
Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells.
2005,
Pubmed
,
Xenbase Carling,
The role of the AMP-activated protein kinase in the regulation of energy homeostasis.
2007,
Pubmed Chan,
Connexin-26-associated deafness: phenotypic variability and progression of hearing loss.
2010,
Pubmed Cohen-Salmon,
Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death.
2002,
Pubmed Decrock,
Connexin-related signaling in cell death: to live or let die?
2009,
Pubmed Denoyelle,
Connexin 26 gene linked to a dominant deafness.
1998,
Pubmed De Vuyst,
Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.
2011,
Pubmed Duquesnes,
Epac stimulation induces rapid increases in connexin43 phosphorylation and function without preconditioning effect.
2010,
Pubmed Elias,
Gap junctions: multifaceted regulators of embryonic cortical development.
2008,
Pubmed Evans,
Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells?
2005,
Pubmed Eybalin,
Glutamine synthetase and glutamate metabolism in the guinea pig cochlea.
1996,
Pubmed Föller,
Regulation of erythrocyte survival by AMP-activated protein kinase.
2009,
Pubmed Föller,
PGE2-induced apoptotic cell death in K562 human leukaemia cells.
2006,
Pubmed Forge,
Gap junctions and connexin expression in the inner ear.
1999,
Pubmed Fraser,
Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK).
2007,
Pubmed
,
Xenbase Grifa,
Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus.
1999,
Pubmed
,
Xenbase Guan,
Chemical hypoxia-induced glucose transporter-4 translocation in neonatal rat cardiomyocytes.
2008,
Pubmed Haack,
Deficient membrane integration of the novel p.N14D-GJB2 mutant associated with non-syndromic hearing impairment.
2006,
Pubmed
,
Xenbase Hallows,
Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells.
2003,
Pubmed
,
Xenbase Hamilton,
An activating mutation in the gamma1 subunit of the AMP-activated protein kinase.
2001,
Pubmed Hardie,
The AMP-activated protein kinase pathway--new players upstream and downstream.
2004,
Pubmed Hills,
TGF-beta1 mediates glucose-evoked up-regulation of connexin-43 cell-to-cell communication in HCD-cells.
2009,
Pubmed Horie,
Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes.
2008,
Pubmed Jensen,
Caffeine-induced Ca(2+) release increases AMPK-dependent glucose uptake in rodent soleus muscle.
2007,
Pubmed Jessen,
Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
2003,
Pubmed Kikuchi,
Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis.
1995,
Pubmed Kikuchi,
Gap junction systems in the mammalian cochlea.
2000,
Pubmed Kudo,
Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness.
2003,
Pubmed Lang,
Functional significance of cell volume regulatory mechanisms.
1998,
Pubmed Lautermann,
Expression of the gap-junction connexins 26 and 30 in the rat cochlea.
1998,
Pubmed Lee,
Connexin-26 mutations in deafness and skin disease.
2009,
Pubmed Lei,
Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo.
2005,
Pubmed Li,
Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
2004,
Pubmed Lira,
Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle.
2007,
Pubmed López-Bigas,
Expression profiles of the connexin genes, Gjb1 and Gjb3, in the developing mouse cochlea.
2002,
Pubmed Lu,
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
2009,
Pubmed Luiken,
Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters.
2004,
Pubmed MacLean,
Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene.
2002,
Pubmed Matsunami,
Gap junctions mediate glucose transport between GLUT1-positive and -negative cells in the spiral limbus of the rat cochlea.
2006,
Pubmed McGee,
AMPK and transcriptional regulation.
2008,
Pubmed Miura,
Role of the gap junction in ischemic preconditioning in the heart.
2010,
Pubmed Mohamed,
Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss.
2010,
Pubmed
,
Xenbase Morizane,
Transient cochlear ischemia and its effects on the stria vascularis.
2005,
Pubmed Natsuizaka,
Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia.
2007,
Pubmed Nojima,
Oleamide derivatives are prototypical anti-metastasis drugs that act by inhibiting Connexin 26.
2007,
Pubmed Oesterle,
Intracellular recordings from supporting cells in the guinea pig cochlea: DC potentials.
1990,
Pubmed Ojuka,
Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro.
2000,
Pubmed Palmada,
Loss of function mutations of the GJB2 gene detected in patients with DFNB1-associated hearing impairment.
2006,
Pubmed
,
Xenbase Park,
Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle.
2009,
Pubmed Sacchi,
Platelet alpha granule release in diabetes mellitus.
1985,
Pubmed Scemes,
Connexins, pannexins, innexins: novel roles of "hemi-channels".
2009,
Pubmed Schneider,
Suicidal erythrocyte death following cellular K+ loss.
2007,
Pubmed Schulz,
Connexin43 and ischemic preconditioning.
2006,
Pubmed Shimizu,
Inhibition of hypertonicity-induced cation channels sensitizes HeLa cells to shrinkage-induced apoptosis.
2006,
Pubmed Sopjani,
Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase.
2010,
Pubmed
,
Xenbase Towler,
AMP-activated protein kinase in metabolic control and insulin signaling.
2007,
Pubmed Turner,
Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels.
2004,
Pubmed Ulfig,
Expression of connexin 26 in the ganglionic eminence of preterm infants after bleedings.
2004,
Pubmed Walker,
5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.
2005,
Pubmed Winder,
Cellular energy sensing and signaling by AMP-activated protein kinase.
2007,
Pubmed Winder,
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.
2000,
Pubmed Xia,
Expression of connexin 26 and Na,K-ATPase in the developing mouse cochlear lateral wall: functional implications.
1999,
Pubmed Xia,
Expression of connexin 31 in the developing mouse cochlea.
2000,
Pubmed Yu,
Epigallocatechin-3 gallate, a green tea catechin, attenuated the downregulation of the cardiac gap junction induced by high glucose in neonatal rat cardiomyocytes.
2010,
Pubmed Zelante,
Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans.
1997,
Pubmed Zhang,
Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions.
2005,
Pubmed Zhao,
Gap junctions and cochlear homeostasis.
2006,
Pubmed Zhao,
Gap junctional hemichannel-mediated ATP release and hearing controls in the inner ear.
2005,
Pubmed Zheng,
Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase.
2001,
Pubmed
